Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Voiding Dysfunction Synonyms and related keywords: detrusor instability, functional voiding disorder, infantile bladder, nonneurogenic neurogenic bladder, non-neurogenic neurogenic bladder, occult neuropathic bladder, unstable urinary bladder, urge incontinence, urge syndrome, Hinman syndrome, patter-of-little-feet syndrome, Author: Stanley Hellerstein, MD, Pediatric Nephrologist, Children's Mercy Hospital of Kansas City; Ernest L Glasscock, MD, Chair in Pediatric Research, Professor of Pediatrics, University of Missouri School of Medicine at Kansas City RESUMEN: Antecedentes: El síndrome miccional, con urgencia, frecuencia, vacilación, goteo de orina y sobre todo incontinencia, reflejan alteraciones en la función de la vejiga urinaria. La patogénesis de los trastornos miccionales se entiende mejor cuando se ve como desviacion del ciclo miccional normal. La capacidad de la vejiga aumenta con el crecimiento. La mayoría de los niños de 1-2 años comienzan a percibir la vejiga llena y desarrollar la capacidad de anular o inhibir la micción, mientras están despiertos. Los niños de 3-5 años han aumentado la sensación de vejiga llena y desarrollan la capacidad de anular o inhibir la micción hasta que el niño decide en que momento y el lugar para orinar. Durante este período, se produce la adquisición de control cortical de la micción. Disfunción miccional no se diagnostica habitualmente en el niño normal antes de la conseguir el control urinario durante el día. Este artículo se centra en trastornos miccionales en niños que no tienen anomalías neurológicas ni obstrucción anatómica del tracto urinario. La enuresis nocturna aislada, que puede ser considerado como un tipo de trastorno de la micción, no se considera aquí. Pathophysiology: The micturition cycle involves 2 discrete processes: bladder filling and storage of urine and bladder emptying. These functions are opposing and normally alternating. Muscular activities of the bladder that result in storage and expulsion of urine are under control of the somatic and autonomic nervous systems. During the filling phase of micturition, regulatory influence of the sympathetic nervous system allows the bladder to expand at low pressure with increasing outlet resistance. Urine storage is a coordinated response of the sympathetic system–mediated inhibition of detrusor contractile activity accompanied by increased muscular tension of the bladder neck and proximal urethra. The primary neurohumoral transmitter for sympathetic activity is norepinephrine; therefore, drugs with adrenergic activity (eg, ephedrine) facilitate the storage of urine. Expulsion of urine normally occurs as a result of simultaneous contraction of the detrusor and relaxation of the bladder outlet. This is mediated by the parasympathetic nervous system, in which the primary neurohumoral transmitter is acetylcholine. Cholinergic agents, such as bethanechol, stimulate bladder emptying. During bladder filling, afferent impulses are transmitted to sensory neurons in the dorsal root ganglia of sacral spinal segments 2-4 and convey information to the brainstem. Nerve impulses from the brainstem inhibit parasympathetic outflow from the sacral spinal micturition center. During the voiding phase, inhibition of the sacral parasympathetic outflow is removed, and detrusor contraction occurs. Inhibition of sympathetic outflow to the bladder results in relaxation of the trigonal and proximal urethral muscles. Impulses traveling along the pudendal nerve act to relax the smooth and skeletal muscle of the external sphincter. The result is expulsion of urine with minimal outlet resistance. CNS control over the lower urinary tract coordinates the micturition cycle. Normal development is characterized by increasing awareness of bladder distension and acquisition of the ability to inhibit voiding at any level of bladder fullness. Voiding symptoms in the neurologically and anatomically intact child, who has neither a urinary tract infection (UTI) nor local urethral irritation, is a result of functional disturbance of the normal micturition cycle. Frequency: In the US: A study of children aged 5-9 years (n = 583) showed that urinary urgency and pelvic-tightening maneuvers to postpone voiding and prevent leakage were the most common voiding problems. Urge incontinence was reported in 7% of girls and 3% of boys. Another study demonstrated that daytime wetting varies by age and sex. The prevalence of daytime wetting with a frequency of at least once every 2 weeks was 10% in children aged 5-6 years, 5% in children aged 6-12 years, and 4% in children aged 12-18 years. Internationally: Studies from the United States and Sweden have addressed the frequency of voiding disorders in school-aged children. A Swedish study of 7-year-old students (n = 3556) showed that 21% of girls and 18% of boys had moderate-to-severe urinary urgency. Daytime urinary incontinence occurred at least once weekly in 3.1% of girls and 2.1% of boys. Mortality/Morbidity: Functional voiding disorders do not cause death. A child with a voiding disorder may have few symptoms or almost continuous urinary tract problems. The child who voids infrequently but who does not have UTIs or urinary incontinence may not be recognized as having a voiding disorder. In contrast, some children with functional voiding disorders have ongoing urge incontinence, urinary dribbling, or recurrent UTIs. These children may experience severe social and emotional problems because of the voiding disorder. A few children with a functional voiding disorder, ie, nonneurogenic neurogenic bladder (Hinman syndrome), have marked voiding dysfunction and may incur significant renal damage. Race: No known studies have shown the incidence of voiding disorders related to race. Clinical experience indicates no racial predilection. Sex: Studies on the prevalence of voiding disorders in school children indicate that daytime urinary incontinence occurs more frequently in girls (6-7%) than in boys (3%). In the authors' voiding dysfunction clinic, girls accounted for 72.6% of children with a functional voiding disorder over a 2-year period. Age: A functional voiding disorder in a neurologically and anatomically healthy child is not usually recognized before the acquisition of daytime urinary control. Many children have a transient period of urinary urgency, occasionally with wetting, when daytime continence is first being achieved. Most of these children develop normal urinary control in a relatively short period; however, some children may have persistence of urinary urgency and wetting, and they subsequently develop additional symptoms of a functional voiding disorder. Other children may have a normal voiding pattern until a UTI or an emotionally traumatic event triggers the onset of a voiding disorder. Approximately 50% of children have symptoms of voiding dysfunction when daytime urinary control is first accomplished. History: Voiding symptoms, such as urgency, frequency, and incontinence may be transient, intermittent, or persistent. Transient voiding symptoms are commonly encountered as a result of nonspecific urethritis or periurethral irritation due to vaginitis or a UTI, or they may occur without a recognized explanation. Symptoms caused by local factors usually clear after the irritant is removed and the local inflammation subsides. Local factors include the following: Detergents in bubble bath or shampoo, which may remove protective secretions from the urethral mucosa Mechanical and chemical irritation from urine-soaked underclothes Local trauma due to tight undergarments Pinworm infestation Hypercalciuria usually causes hematuria, along with dysuria and urinary urgency, but it may also cause voiding symptoms with scant hematuria. Extraordinary daytime urinary frequency (patter-of-little-feet syndrome) has the following characteristics: This disorder occurs in a toilet-trained child of preschool or elementary school age. It is characterized by the sudden onset of painless urinary frequency. Urinary urgency may occur as often as every 5 minutes, though, in most children, it occurs 3-4 times per hour. In some, urinary frequency is most marked in the morning or afternoon. Urinary frequency does not occur at night. In most instances, incontinence is not present. Nocturnal enuresis, if present, is unchanged or mildly increased. Children with this condition do not have a UTI, hypercalciuria, or other known local or systemic disorder that accounts for the urinary frequency. A key diagnostic feature is that urinary frequency occurs during the day, with not significant change in the nighttime voiding pattern. The etiology is unknown. Asymptomatic daytime urinary incontinence in a child with daytime urinary control Many children aged 3-5 years tend to delay urination because of intense concentration on playing or watching television. As a result, they occasionally have damp or soaked clothing. If the voiding pattern is otherwise normal, this pattern of voiding dysfunction usually subsides without intervention. Occasionally, an older child who has had a normal daytime voiding pattern for months or years may inexplicably develop asymptomatic daytime incontinence. Rule out UTI. Daytime urinary incontinence usually clears within a few days to 2 weeks without intervention. Other factors may result in daytime dampness or wetting. Vaginal reflux of urine may cause dampness when the child assumes an upright posture after voiding. This is particularly likely in an obese girl in whom the labia do not open widely during urination because of the thickness of her thighs. The diagnosis may be confirmed by having the child void in a reverse sitting position while embracing the toilet tank or its equivalent or by have the child widely extend his or her thighs while voiding in the usual position. Interlabial adhesions of the labia minora may cause daytime wetting due to the pooling of urine in the vagina. Treatment of the labial adhesions eliminates this cause of urinary incontinence. Persistent but otherwise asymptomatic daytime urinary incontinence with dribbling or overt wetting may have an underlying neurologic, anatomic, or functional basis. Daytime wetting is considered a problem in the developmentally normal child aged 4 years or older who is wet several days each week and in the previously continent child who develops daytime wetting. If dribbling and ongoing wetting have been present lifelong, an ectopic ureter should be ruled out by using imaging studies such as a CT or an intravenous pyelography (IVP). The diagnoses of detrusor instability or a neurogenic bladder are usually evident from the patient's history, but results of voiding cystourethrography (VCUG) may suggest the condition. In some instances, urodynamic study may be needed to define the cause of relatively asymptomatic daytime incontinence. Asymptomatic daytime wetting, as well as symptomatic daytime urinary incontinence, in a previously continent child suggests the possibility of sexual abuse or other trauma. Giggle incontinence This is the occurrence of involuntary complete bladder evacuation induced by laughter. This typically appears in children aged 5-7 years. It persists throughout the school years and usually improves or disappears with age. The voiding pattern is otherwise normal. Episodes of incontinence may occur with giggling in some children; in others, they are induced by only vigorous laughter. The etiology is unknown. Giggle incontinence is not a form of stress incontinence, nor is it due to weakness of the sphincter. The authors of 1 study found a high incidence of daytime voiding symptoms in patients in whom they diagnosed giggle incontinence. The authors concluded that laughter induced unstable detrusor contractions in children susceptible to detrusor instability. Detrusor instability This is the cause of urge syndrome and urge incontinence in children who do not have a UTI. It is the result of overactive detrusor contractions during the filling phase of micturition. Voiding symptoms result from detrusor contractions during bladder filling. During voiding, outlet relaxation and normal bladder emptying occur. This voiding disorder often occurs in children with recurrent UTIs and is a risk factor for UTI for which effective intervention is possible. The children are commonly seen because of 1 or more UTI or daytime urinary incontinence. A careful history usually reveals that the child has had ongoing urinary urgency with various posturing maneuvers in an attempt to prevent incontinence. Urinary urgency and risk of urge incontinence occur during bladder filling because of uninhibited detrusor contractions. This appears to result from a lack of inhibitory cerebral control over reflex detrusor contractions during bladder filling. The problem may have been present since daytime urinary control began developing, or it may appear in a child who previously had a normal voiding pattern. The appearance of detrusor instability in a child who previously had daytime urinary control may occur after a UTI or it may appear with no apparent triggering event. Children with urge syndrome and urge incontinence who do not attempt to prevent wetting by posturing maneuvers that compress the urethra are probably not at increased risk for UTIs. Those who use posturing maneuvers are at risk for UTI because of “milking back” of bacteria-laden urine from the distal urethra into the urinary bladder (urethrovesical reflux). Obstruction of the urethra during a detrusor contraction causes high intravesical pressure. Increased intravesical pressure has been shown to contribute to persistence of vesicoureteric reflux (VUR) and to the recurrence of VUR after ureteral reimplantation. Stool retention is common in children with urinary urgency who use pelvic withholding maneuvers to prevent incontinence. When chronic constipation has been present in a child with a voiding disorder, it may be the primary cause of bladder dysfunction. More commonly, constipation is secondary to the use of anticholinergic medication and/or contraction of the pelvic floor and urogenital diaphragm to prevent incontinence. The urogenital diaphragmatic component of the external sphincter is primarily a skeletal muscle, over which one has voluntary control. Contraction of this muscle normally inhibits detrusor contractility, but it is also associated with contraction of the anal sphincter. Dysfunctional voiding This is caused by overactivity of the pelvic floor muscles during the voiding phase of the micturition cycle. The syndromes due to dysfunctional voiding vary from mild daytime frequency and post void dribbling to daytime and nighttime wetting, urgency, urge incontinence, pelvic holding maneuvers, and UTIs. In the most severe form, children with dysfunctional voiding resemble those with anatomic or neurologic bladder outlet obstruction. Although the etiology is not known, it is thought to reflect a deviation in the normal development of urinary control. Normal micturition consists of a sustained detrusor contraction with concomitant relaxation of the bladder outlet and complete bladder emptying at normal voiding pressures. As daytime urinary control is being accomplished, many children have a transitional phase in which pelvic withholding maneuvers are used to prevent incontinence. This is not necessarily abnormal; contraction of the external urethral sphincter, which occurs with pelvic floor musculature contraction, causes physiologic inhibition of a detrusor contraction. Most children eventually develop a pattern of coordinated voiding, with central control over detrusor and bladder outlet contractions that make it unnecessary to contract the external sphincter to prevent incontinence. A few children who have a delay in establishing cerebral control over detrusor contractions continue to use pelvic-tightening maneuvers. Over time, these maneuvers appear to become involuntary. Some have suggested that this pattern of dysfunction of the muscles of the pelvic floor is a consequence of overtraining of the urinary bladder. Children with this condition have ongoing symptoms of voiding dysfunction with increased intravesical pressure on voiding, incomplete bladder emptying, UTIs, persistent VUR, dilatation of the upper tract, and (sometimes) renal damage. Evaluation should include VCUG, urinary tract ultrasonography, urodynamic studies, and (in some instances) MRI of the lumbosacral spine to rule out a neurologic etiology. The appearance of the urinary bladder may be similar to that of a patient with posterior urethral valves or a neurogenic bladder. Lazy bladder syndrome This term describes the voiding disorder in children who void infrequently. Infrequent voiding is diagnosed if a child voids 3 or fewer times in 24 hours or if a child does not void for 12 hours. This voiding pattern may be a variant of normal. It is not clinically significant if urgency with voiding, UTIs, and incontinence are absent. However, if identified, the voiding pattern should be treated with behavioral modification of the child's voiding regimen. If symptoms are present, the pattern of infrequent voiding is clinically important. The detrusor muscle may be hypocontractile; voiding may be accomplished by increased intra-abdominal pressure as the driving force to expel urine. The diagnosis may be confirmed by means of urodynamic study. Dysfunctional elimination syndrome Constipation and detrusor instability are so frequently associated that the term dysfunctional elimination syndrome has been introduced in the literature. In many instances, constipation is the primary or contributing cause of a voiding disorder; therefore, this should always be considered in the evaluation of a child with symptoms of detrusor instability. Many people are reluctant to discuss their stooling history. In most instances, bowel movements are considered a private matter. Often, neither the child nor the parent appears to have accurate information about stooling frequency or character. The effects of constipation on bladder function are related to the retained fecal material distending the rectosigmoid colon. Indicators of constipation include the following: Infrequent passage of stools Small hard stools or elongated wide-bore stools Palpable stool on abdominal examination Dilated rectal vault on digital examination Skid marks in the underwear (often interpreted as due to improper or careless wiping) Encopresis Large quantities of stool in the colon, and especially the rectosigmoid area on abdominal radiography Physical: No notable positive findings are noted on physical examination of the child with a functional voiding disorder. Perform careful physical examination to rule out a suprapubic mass or abnormality of the lumbosacral area that suggests occult spinal dysraphism. The latter includes a sacral dimple or tuft of hair, dermal vascular malformations, a small lipomeningocele, or absence of the gluteal cleft with flattened buttocks (sacral agenesis). Carefully examine the genitalia to be certain they are normal. Look for labial adhesions in girls and meatal stenosis in boys. In the young girl, the genitalia should be examined to rule out sexual abuse. In most instances, the anus should be inspected, perianal sensation should be checked, and a digital examination of the rectum should be performed. Normal anal sphincter tone suggests normal neurologic input to the bladder. Causes: Voiding dysfunction may be caused by uninhibited detrusor contractions (detrusor instability), dysfunction of the pelvic floor musculature (dysfunctional voiding), or a combination of these. Detrusor instability is evident during the filling phase of the micturition cycle. This reflects a detrusor contraction when an individual who has (or should have) urinary control should be able to inhibit micturition. Detrusor instability is due to lack of central inhibition of cholinergic stimulating nerve impulses from the sacral micturition center. (This pattern of voiding dysfunction in a child with neurogenic bladder, such as occurs with myelodysplasia, is called detrusor hyperreflexia.) Dysfunctional voiding occurs because of incomplete or total absence of relaxation of the pelvic floor musculature during a detrusor contraction. Voluntary contraction of the pelvic floor musculature to prevent urinary incontinence is not uncommon, nor necessarily abnormal, when a child is first learning urinary control. When voluntary contraction of the pelvic floor musculature is regularly used to prevent incontinence, this response may become involuntary and cause dysfunctional voiding. Some have suggested that dysfunction of the pelvic floor musculature is a consequence of overtraining of the urinary bladder. It may have its onset during the acquisition of urinary control in early childhood, or it may develop later, often after a UTI in which local irritation has caused dysuria and urgency. (This pattern of voiding incoordination in a child with a neurogenic bladder is called detrusor sphincter dyssynergia.) Lab Studies: Urinalysis and quantitative urinary cultures may be performed to detect or rule out a UTI. Imaging Studies: VCUG, radiography of the lumbosacral spine, contrast-enhanced CT, or MRI of the lumbosacral spine is needed in select cases. If dribbling and ongoing wetting have been present lifelong, a neurogenic bladder or anatomic anomaly (eg, ectopic ureter) must be ruled out. The best study for this evaluation is contrast-enhanced CT, though IVP was commonly used in the past. Procedures: If neither the patient's history nor VCUG provides an explanation for the voiding disorder, urodynamic studies should be conducted to detect uninhibited detrusor contractions, dysfunction of the pelvic floor muscles, or a hypotonic bladder. Medical Care: Extraordinary daytime urinary frequency Reassure the parents and the child that no significant underlying pathology is present and that the condition will spontaneously resolve. Resolution usually occurs after a few weeks, though some cases of urinary frequency can persisted for many months. In a report of 46 children with the syndrome, symptoms lasted 2 weeks to 42 months. The average time of resolution after onset was 7.4 months for boys and 13.5 months for girls. Interventions are empiric and include avoidance of caffeine-containing foods and beverages and carbonated drinks. In addition, encourage children to attempt to lengthen the periods between voids as long as they can to do so without undue discomfort or risk of incontinence. Asymptomatic daytime urinary incontinence Wetting secondary to vaginal reflux may be resolved by having the girl pay close attention to complete emptying of the vaginal vault on voiding. This is accomplished by spreading the labia majora when she urinates. If this is unsuccessful, the child may assume an upright position over the commode immediately after voiding to empty the vagina. Alternatively, the child may void in a reverse sitting position on the commode, which causes the thighs to be abducted and the labia majora to separate. Labial adhesions have been attributed to local inflammation caused by less-thanoptimal genital hygiene in association with the hypoestrogenic state of a preadolescent child. In many instances, lack of good genital hygiene does not appear to play a role; however, local irritation caused by aggressive cleansing may. Use of a warm-water sitz bath for 10-15 minutes 2-3 times a day may be the best way to cleanse the vaginal area in an infant or young girl. Fecal contamination should be wiped from the perineal area before the bath. Recommended treatment consists of genital hygiene and application of a topical estrogen cream to only the fused area. Elimination of the adhesions may take 2-8 weeks. After the adhesions have separated, a bland petroleum jelly should be applied to the medial surfaces of the labia minora once daily for 1-2 months. If no specific diagnostic etiology is found, management of persistent otherwise asymptomatic daytime urinary incontinence is primarily supportive. All caffeinecontaining foods and beverages should be eliminated, and an anticholinergic agent should be introduced. A trial with diazepam may be helpful because of the psychological side effects of persistent daytime urinary incontinence. Ongoing support from the physician and family is essential, and professional psychiatric help may be warranted. Treatments for giggle incontinence are proposed and based on various hypotheses concerning the etiology. Results are difficult to assess because of the high rate of resolution with maturity. Those who hypothesize that giggle incontinence is a special form of detrusor instability have used timed voiding, anticholinergic agents, and imipramine (see the Medication section below). Patients may need to accommodate the problem by trying to avoid situations that cause laughter when in public places. If incontinence occurs frequently, a trial of an anticholinergic agent with a timed voiding schedule may be warranted. Detrusor instability The goal is to foster development of cerebral inhibition of detrusor contractions during bladder filling so that urgency and urge incontinence do not occur. No known medication or procedure is has been shown to accomplish this; however, certain interventions appear to help. Anticholinergic medications (see the Medication section below) are frequently helpful. However, these medications are meant to help the child develop a normal voiding pattern and not long-term solutions. Ultimately, the child must develop the ability to use cerebral mechanisms to inhibit detrusor contractions. A voiding retraining program is an essential component of the management of the child. In most instances, the voiding retraining program should be tried for 2-3 weeks before an anticholinergic medication is introduced. Guidelines for a voiding retraining program include the following: Small girls should have a footstool or other solid surface placed in front of the commode so that their feet are on a solid surface. Girls should remove their underpants or lower them to the ankles to permit relaxed separation of the thighs. During voiding, the child should be comfortable and relaxed. Neither boys nor girls should rush to void (eg, during a television commercial). Boys should be instructed to free their penis before voiding. The zipper or buttons should be completely opened. If the underwear constricts the penis, this should be corrected. The boys should be relaxed and take sufficient time to completely empty the bladder. Successful management requires ongoing support, instruction, and education. Children should be helped to understand that normal urination is the result of relaxing the sphincters and permitting the bladder muscle to expel the urine, not a matter of forced voiding using the abdominal muscles. A timed voiding schedule should be used when the child is awake, even in those with urinary frequency. Children should develop a regular voiding pattern, with bladder evacuation every 1.5-2 hours. This is a basic component of bladder retraining. Writing letters to a school nurse, teacher, or principal to carry out this program is almost always necessary and of value. Introduce calendars to keep record of the voiding pattern and bowel movements. The latter is important, even in the child with no history of constipation, particularly if an anticholinergic medication is introduced. Ongoing management may be accomplished via telephone, if the family keeps good records. Suppressive antibacterial therapy should be used for children with recurrent UTIs and those with VUR. Dysfunctional voiding (pelvic floor muscular dysfunction with or without uninhibited detrusor instability) Treatment of this voiding disorder, which has been described as a disharmony between the detrusor and sphincters, consists of a voiding retraining program with emphasis on good voiding technique, suppressive antibacterial agents for those prone to UTIs, anticholinergic medication, and (in some instances) an alpha1adrenergic receptor blocker (see the Medication section below). Prevent constipation. Dysfunctional voiding is the most worrisome functional voiding disorder in children because it may progress in a pattern similar to a neurogenic bladder or outlet obstruction. In the infrequent instances of severe functional bladder outlet obstruction the condition has been termed occult neuropathic bladder, nonneurogenic neurogenic bladder, psychological nonneuropathic bladder, and Hinman syndrome. When the upper urinary tract is normal, management should focus on the development of effective relaxed voiding using the interventions described for detrusor instability. Biofeedback training for carrying-out Kegel exercises (pelvic floor relaxation and contraction) has been successful in many centers. Persistent symptoms, including dribbling of urine, incomplete emptying, and bladder spasms may be alleviated using an alpha1-adrenergic receptor blocker in addition to an anticholinergic drug. Diazepam, psychological counseling, hypnosis, and biofeedback have been used with varying degrees of success. If these approaches are unsuccessful, particularly in children with upper tract damage, a trial of clean intermittent catheterization should be introduced. Residual urine should be checked to monitor progress. In rare instances, those with compromised upper urinary tracts who do not improve with the preceding measures may benefit from temporary urinary diversion. Lazy bladder syndrome Children who void as infrequently as 2-3 times every 24 hours but who do not have UTIs, urinary urgency, or incontinence do not have a discrete clinical indication for intervention. However, encouraging more frequent voiding may be wise to avoid potential problems at a later age. Children who void infrequently and who are prone to UTIs or have urgency or incontinence should be encouraged to empty their urinary bladders every 2-3 hours. They are at risk for UTIs because prolonged bladder incubation of urine compromises the protective effect of regular bladder washout, which clears bacteria that gain access to the bladder during voiding due to eddy currents. Urinary incontinence is usually due to overflow from a large hypotonic bladder. Those with persistent voiding symptoms or UTIs should undergo urodynamic evaluation. Children with large capacity hypotonic urinary bladders who are unwilling or unable to comply with an improved voiding schedule should have a trial on bethanechol (see the Medication section below). If bethanechol is not helpful, clean intermittent catheterization may be needed for a period. Constipation and detrusor instability When constipation is diagnosed in a child with detrusor instability, treating the constipation is important to determine if it is the cause of bladder instability and to improve bowel evacuation. Anticholinergic medications, which are frequently administered to control uninhibited detrusor contractions, also act on the musculature of the rectosigmoid colon and foster fecal retention. Treatment of chronic constipation requires initial complete evacuation of the colon followed by ongoing high-fiber diet and medication. Although daily enemas may be used, one option is relatively aggressive treatment with a solution of polyethylene glycol and electrolyte (see the Medication section below), which is prepared by diluting the powder and administering it once a day or more frequently. This therapy has gained widespread use for evacuation of the colon. Pharmacologic therapy of voiding dysfunction in children usually centers on inhibiting unexpected detrusor contractions and, at times, decreasing bladder outflow resistance. Most of the neurohumoral stimulus for bladder contraction is the stimulation of muscarinic-cholinergic receptor sites on bladder smooth muscle. Atropine and atropinelike agents can depress normal and uninhibited bladder contractions. In some instances, bladder outlet resistance is increased because of stimulation of alpha1-adrenergic receptors in the bladder neck. This effect may be decreased by the use of alpha1-adrenoreceptor blockers. Management of constipation is also an important component of treatment of voiding dysfunction in children. Drug Category: Anticholinergic agents -- These drugs inhibit the binding of acetylcholine to the cholinergic receptor, thereby suppressing involuntary bladder contraction of any etiology. In addition, they increase the volume of the first involuntary bladder contraction, decrease the amplitude of the involuntary bladder contraction, and possibly increase bladder capacity. Drug Name Hyoscyamine (Levsin) -- L-isomer of hyoscyamine, which is almost entirely responsible for antimuscarinic activity of atropine. Atropine is racemic mixture D/L-hyoscyamine. Adult Dose 0.125-0.3 mg PO qid Pediatric Dose 0.003 mg/kg/d PO divided bid; not to exceed 0.1 mg/kg/d divided qid Contraindications Documented hypersensitivity; obstructive uropathy; narrow-angle glaucoma; myasthenia gravis; obstructive GI tract disease Interactions Effects decrease with concurrent antacids; toxicity increases with concurrent phenothiazines, amantadine, haloperidol, MAOIs, and tricyclic antidepressants Pregnancy C - Safety for use during pregnancy has not been established. Precautions Impairment of sweating may limit use in children during vigorous exercise on hot days; observe for development or aggravation of constipation and impairment of sweating; must titrate dose for effectiveness without unacceptable adverse effects Drug Name Propantheline bromide (Pro-Banthine) -- Quaternary ammonium antimuscarinic with peripheral effects similar to those of atropine. Adult Dose 15 mg PO bid/qid Pediatric Dose 0.5 mg/kg/d PO/SL divided bid; not to exceed 0.5 mg/kg/d divided qid Contraindications Documented hypersensitivity; ulcerative colitis; narrow-angle glaucoma; obstructive disease of the GI or urinary tract Interactions Effects decrease with concurrent antacids; toxicity increases with concurrent disopyramide, tricyclic antidepressants, phenothiazines, corticosteroids, and bretylium Pregnancy C - Safety for use during pregnancy has not been established. Precautions Impairment of sweating may limit use in children during vigorous exercise on hot days; observe for development or aggravation of constipation and impairment of sweating; must titrate dose for effectiveness without unacceptable adverse effects Drug Name Oxybutynin (Ditropan, Ditropan XL) -- Synthetic tertiary amine; like atropine, antagonizes muscarinic actions of acetylcholine. Direct spasmolytic effect on detrusor muscle and small intestine and local anesthetic action. Reduces incidence of uninhibited detrusor contractions. Adult Dose 5 mg PO bid/qid or extended release 5-10 mg qd; increase in 5-mg increments; not to exceed 30 mg/d Pediatric Dose Immediate release: 1-5 years: 0.2 mg/kg/dose 2-3 times/d >5 years: 5 mg bid; up to 5 mg 3 times/d Extended release: ¡Ý6 years: 5 mg qd; increase in 5-mg increments as tolerated; maximum 20 mg/d Contraindications Documented hypersensitivity; ulcerative colitis; narrow-angle glaucoma; obstructive disease of the GI or urinary tract Interactions CNS effects increase when administered concurrently with other CNS depressants Pregnancy B - Usually safe but benefits must outweigh the risks. Precautions Do not chew or crush extended-release tablets; impairment of sweating may limit use in children during vigorous exercise on hot days; observe for development or aggravation of constipation and impairment of sweating; behavioral changes necessitate discontinuation to determine if drug is the cause; must titrate dose for effectiveness without unacceptable adverse effects Drug Name Imipramine (Tofranil) -- Tricyclic antidepressant. Facilitates urine storage by decreasing bladder contractility and increasing outlet resistance. Adult Dose 10-25 mg PO qd/tid initially and increase gradually prn; not to exceed 200 mg/d Pediatric Dose <6 years: Not recommended 6-12 years: 0.7-1.2 mg/kg/d PO divided bid >12 years: 1.2 mg/kg/d PO divided tid; not to exceed 200 mg/d Contraindications Documented hypersensitivity; narrow-angle glaucoma; in acute recovery phase following myocardial infarction; concurrent administration of MAOIs or fluoxetine or administration in the previous 2 wk (avoid) Interactions Increases toxicity of sympathomimetic agents (eg, as isoproterenol, epinephrine) by potentiating effects and inhibiting antihypertensive effects of clonidine Pregnancy D - Unsafe in pregnancy Precautions Consider baseline ECG in all patients; before use, perform cardiac evaluation in those with family history of sudden death, baseline PR interval >90th percentile for age, or any alteration in intraventricular conduction; long-term high-dose therapy should not be abruptly discontinued; caution in seizure disorders, hyperthyroidism, or thyroid replacement therapy Drug Category: Alpha1-adrenergic antagonists -- These agents are used to decrease smooth muscle tone in the bladder outlet. Drug Name Doxazosin mesylate (Cardura) -- Selective inhibitor of alpha1-adrenergic receptors. Blockade of these receptors in bladder neck decreases outflow resistance. Available as tablet. Adult Dose 1 mg PO qhs initially to avoid the first-dose effect; may be increased gradually over 1-2 wk; not to exceed 8 mg/d for urodynamic effect Pediatric Dose 0.5 mg PO qhs initially to avoid first-dose effect; may increase by 0.5 mg after interval of several wk; not to exceed 2 mg/d; safety and effectiveness not determined Contraindications Documented hypersensitivity Interactions Effects decrease with coadministration of NSAIDs; effects increase with coadministration of diuretics and antihypertensive medications Pregnancy B - Usually safe but benefits must outweigh the risks. Precautions Caution in renal impairment; may cause marked hypotension following first dose Drug Name Terazosin hydrochloride (Hytrin) -- Selective inhibitor of alpha1-adrenergic receptors. Blockade of these receptors in bladder neck decreases outflow resistance. Available only as capsule. Adult Dose 1 mg PO qhs; increase slowly to effect; not to exceed 20 mg/d Pediatric Dose 1 mg PO qhs initially to avoid first-dose effect; dose should not be increased for several wk; not to exceed 2 mg/d; safety and effectiveness not determined Contraindications Documented hypersensitivity Interactions Effects decrease with coadministration of NSAIDs; effects increase with coadministration of diuretics and antihypertensives Pregnancy B - Usually safe but benefits must outweigh the risks. Precautions Caution in renal impairment; may cause marked hypotension following first dose and coadministration with beta-blockers Drug Name Polyethylene Glycol 3350 NF Powder for solution (Miralax, GlycoLax) -Polyethylene glycol solution is osmotic agent that causes water to be retained in stool. Despite lack of specific recommendations, widely given to children with voiding dysfunction by primary care physicians, pediatric gastroenterologists, and pediatric nephrologists caring for children. Recommended for occasional constipation in adults. Adult Dose 17 g/din 8 oz water, juice, soda, coffee, or tea Pediatric Dose Not established; no recommended dose in manufacturer's literature, Physicians' Desk Reference (2005) or Pediatric Dosage Handbook (2005); 8.5-17 g in 8 oz. fluid qd/qod being used; prolonged use may be common because of ongoing constipation Contraindications GI obstruction, gastric retention, bowel perforation, megacolon Interactions None if used for occasional constipation; when used for bowel cleansing, increased peristalsis may decrease absorption of oral medications Pregnancy C - Safety for use during pregnancy has not been established. Precautions Caution in ulcerative colitis, impaired gag reflex, or regurgitation or aspiration during administration; treatment duration for occasional constipation should not exceed 2 wk Further Outpatient Care: Ongoing follow-up is essential. Most follow-up visits can be handled with regular telephone contact with the parents or the child if they monitor voiding and stooling. Parents and children should pay attention to maintenance of the recommended voiding interventions and to bowel function with regard to constipation. Medication changes can be made by means of ongoing telephone contact. Complications: Persistence of daytime wetting may markedly disrupt the social lives of older children. Detrusor instability with pelvic withholding maneuvers may foster recurrent UTIs or persistence of VUR. Dysfunctional voiding can cause persistence of VUR and frequent UTIs. In rare cases, this results in dilatation of the upper urinary tract and kidney damage. Prognosis: The prognosis for complete or partial resolution of a functional voiding disorder is excellent for children with daytime urinary incontinence and detrusor instability. The prognosis is good for children with giggle incontinence, who tend to outgrow it during adolescence and for those with lazy bladder syndrome, who respond to intervention. The prognosis is guarded for children with dysfunctional elimination syndromes and dysfunctional voiding whose condition does not respond to intervention. Patient Education: Patients should be educated about voiding retraining. This is the foundation of the treatment of children with functional voiding disorders. Although how a child achieves cerebral control over reflex detrusor contractions is unclear, learning good voiding patterns appears to be helpful. Effective biofeedback training is especially helpful for management of muscular dysfunction of the pelvic floor. * Allen TD: The non-neurogenic neurogenic bladder. J Urol 1977 Feb; 117(2): 2328[Medline]. * Bloom DA, Faerber G, Bomalaski MD: Urinary incontinence in girls. Evaluation, treatment, and its place in the standard model of voiding dysfunctions in children. Urol Clin North Am 1995 Aug; 22(3): 521-38[Medline]. * Chandra M: Voiding and its disorders in children. In: Monographs in Clinical Pediatrics. Series Volume 10. Amsterdam: Harwood Academic; 1998: 217-229. * Chandra M, Saharia R, Shi Q: Giggle incontinence in children: a manifestation of detrusor instability. J Urol 2002 Nov; 168(5): 2184-7; discussion 2187[Medline]. * Chen JJ, Mao W, Homayoon K: A multivariate analysis of dysfunctional elimination syndrome, and its relationships with gender, urinary tract infection and vesicoureteral reflux in children. J Urol 2004 May; 171(5): 190710[Medline]. * Cooper CS: Current management of dysfunctional voiding. Dial Pediatr Urol 2002; 25(8): 1-8. * De Paepe H, Renson C, Van Laecke E: Pelvic-floor therapy and toilet training in young children with dysfunctional voiding and obstipation. BJU Int 2000 May; 85(7): 889-93[Medline]. * Dohil R, Roberts E, Jones KV: Constipation and reversible urinary tract abnormalities. Arch Dis Child 1994 Jan; 70(1): 56-7[Medline]. * Glazier DB, Ankem MK, Ferlise V: Utility of biofeedback for the daytime syndrome of urinary frequency and urgency of childhood. Urology 2001 Apr; 57(4): 791-3; discussion 793-4[Medline]. * Hellerstein S, Stern L, Alon U: Voiding dysfunction in pediatric patients: a clinical approach to diagnosis and management. Children's Hospital Quarterly 1990; 2(3): 213-225. * Hellerstein S, Linebarger JS: Voiding dysfunction in pediatric patients. Clin Pediatr (Phila) 2003 Jan-Feb; 42(1): 43-9[Medline]. * Hellerstein S, Zguta AA: Outcome of overactive bladder in children. Clin Pediatr (Phila) 2003 Jul-Aug; 42(6): 553-6[Medline]. * Hoebeke P, Vande Walle J, Everaert K: Assessment of lower urinary tract dysfunction in children with non-neuropathic bladder sphincter dysfunction. Eur Urol 1999 Jan; 35(1): 57-69[Medline]. * Homsy YL: Constipation and UTI. Dialog Pediatr Urol 1998; 21(12): 5-7. * Kramer SA, Rathbun SR, Elkins D: Double-blind placebo controlled study of alpha-adrenergic receptor antagonists (doxazosin) for treatment of voiding dysfunction in the pediatric population. J Urol 2005 Jun; 173(6): 2121-4; discussion 2124[Medline]. * McKenna PH, Herndon CD, Connery S: Pelvic floor muscle retraining for pediatric voiding dysfunction using interactive computer games. J Urol 1999 Sep; 162(3 Pt 2): 1056-62; discussion 1062-3[Medline]. * McKenna PH, Herndon CD: Voiding dysfunction associated with incontinence, vesicoureteral reflux and recurrent urinary tract infections. Curr Opin Urol 2000 Nov; 10(6): 599-606[Medline]. * Mota DM, Victoria CG, Hallal PC: [Investigation of voiding dysfunction in a population-based sample of children aged 3 to 9 years]. J Pediatr (Rio J) 2005 May-Jun; 81(3): 225-32[Medline]. * Norgaard JP, van Gool JD, Hjalmas K: Standardization and definitions in lower urinary tract dysfunction in children. International Children's Continence Society. Br J Urol 1998 May; 81 Suppl 3: 1-16[Medline]. * O'Regan S, Yazbeck S, Schick E: Constipation, bladder instability, urinary tract infection syndrome. Clin Nephrol 1985 Mar; 23(3): 152-4[Medline]. * Robson WL: Diurnal enuresis. Pediatr Rev 1997 Dec; 18(12): 407-12; quiz 412[Medline]. * Rogers MP, Gittes RF, Dawson DM: Giggle incontinence. JAMA 1982 Mar 12; 247(10): 1446-8[Medline]. * Rushton HG: Wetting and functional voiding disorders. Urol Clin North Am 1995 Feb; 22(1): 75-93[Medline]. * Schulman SL, Quinn CK, Plachter N: Comprehensive management of dysfunctional voiding. Pediatrics 1999 Mar; 103(3): E31[Medline]. * Zoubek J, Bloom DA, Sedman AB: Extraordinary urinary frequency. Pediatrics 1990 Jun; 85(6): 1112-4[Medline].